THEAL-F: Plantar Fasciitis Treatment: Influence of the Possible Presence of Subchondral Bone Edema

Sponsor
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05925777
Collaborator
(none)
24
1
2
42.1
0.6

Study Details

Study Description

Brief Summary

Standard treatments of plantar fasciitis include stretching exercises of the posterior muscle chain and plantar fascia, taking anti-inflammatories, cortisone infiltration or biostimulation with physical therapies (low energy laser therapy, shock waves, ultrasound therapy, etc.). In non-responsive forms to conservative treatments, surgical treatment can be undertaken.

Laser therapy is indicated for plantar fasciitis, in particular for its biological anti-inflammatory, anti-edema and reparative effects on the plantar fascia; to date, the potential effects also on the underlying bone edema component, when present, which aggravates and self-maintains the ongoing pathology are not known.

Condition or Disease Intervention/Treatment Phase
  • Device: THEAL (Mectronic, Bergamo)
N/A

Detailed Description

Plantar fasciitis is one of the most common causes of heel pain; the pain is more intense in the morning, tends to decrease during the day with movement, to flare up after sitting for a long time. It presents itself as inflammation and contextual degeneration of the insertion of the fascia that covers the muscles present at the level of the sole of the foot, with progressive evolution and possible calcification of the insertion. The incidence is between 9 and 20% of the population, with a higher incidence in middle-aged obese women and in young male runners. The diagnosis makes use of radiography, to verify any local deformities or the presence of the subcalcaneal spur, and ultrasound, to investigate the integrity of the fascia and its thickening. MRI images are useful for better studying the heel bone and plantar fascia, especially for discerning other various causes of heel pain, including stress fractures, tarsal tunnel syndrome, and Achilles tendinopathy. Signal changes with bone edema are sometimes found in association with plantar fasciitis and may be indicative of or represent the result of avulsive trauma, stress, intraspongious fractures or a combination of these situations. These MRI images are similar to those described in the elbow in some patients with epicondylitis, where overuse can cause increased bone edema on T2-weights. Previous studies have shown the presence of bone edema at the level of the heel on MRI in 35% of patients with plantar fasciitis. Plantar fascia evaluation with a dedicated magnetic resonance scanner in weight-bearing position: our experience in patients with plantar fasciitis and in healthy volunteers. Maier et al demonstrated that the presence of calcaneal bone edema is a highly predictive factor for improved response to shock wave treatment. Often the finding of a thickening of the fascia and the signal changes of the soft tissues do not correlate with the clinical response, while the presence of bone edema is highly predictive (positive predictive value 0.94, sensitivity 0.89, specificity 0.8).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
randomized prospectiverandomized prospective
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Plantar Fasciitis Treatment: Influence of the Possible Presence of Subchondral Bone Edema
Anticipated Study Start Date :
Jul 1, 2023
Anticipated Primary Completion Date :
Jul 1, 2026
Anticipated Study Completion Date :
Jan 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: experimental group

The protocol provides for the administration of 10 polymodal high energy laser therapy sessions, to be carried out every other day. The THEAL device (Mectronic, Bergamo) allows to deliver 4 wavelengths (650 nm, 810 nm, 980 nm and 1064 nm), with continuous and pulsed mode, with power up to 20 W. Patients will perform stretching exercises like those of the control group.

Device: THEAL (Mectronic, Bergamo)
laser therapy high intensity
Other Names:
  • laser
  • No Intervention: Control group

    Patients will perform four daily stretching exercises (three sets of 30 seconds), for 6 weeks. Hamstring and ankle plantar flexor stretch (straight leg raise in supine position) self-stretching of the surae muscles: the patient bends forward in a standing position with the affected foot farthest from the wall, keeping the heel on the floor; 3. the soleus muscle is exercised with the knee flexed and the gastrocnemius muscle with the knee extended 4. Plantar fascia self-stretch: In a seated position, the patient crosses the affected foot over the contralateral thigh and passively extends the metatarsophalangeal joints . In the first session, the volunteers will be trained on how to perform the exercises correctly and will be monitored once a week.

    Outcome Measures

    Primary Outcome Measures

    1. recovery of pain [change between baseline to 2 months]

      The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain."

    2. recovery of pain [change between baseline to 6 months]

      The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain."

    Secondary Outcome Measures

    1. functional recovery [change between baseline to 2 months]

      The Foot Function Index (FFI) measures the effect of foot problems on function in terms of pain and disability.The scores range from 0 to 100; the higher the score, the more limitation/pain/disability is present. The scores range from 0 to 100; the higher the score, the more limitation/pain/disability is present.

    2. functional recovery [change between baseline to 6 months]

      The Foot Function Index (FFI) measures the effect of foot problems on function in terms of pain and disability.The scores range from 0 to 100; the higher the score, the more limitation/pain/disability is present. The scores range from 0 to 100; the higher the score, the more limitation/pain/disability is present.

    3. perception of clinical improvement [change between baseline to 2 months]

      Maudsley and Roles scale scores range from 0-4 points for excellent to poor

    4. perception of clinical improvement [change between baseline to 6 months]

      Maudsley and Roles scale scores range from 0-4 points for excellent to poor

    Other Outcome Measures

    1. band thickness [change between baseline to 2 months]

      ultrasound image to measure of fascia thickness, measured in mm

    2. band thickness [change between baseline to 6 months]

      ultrasound image to measure of fascia thickness, measured in mm

    3. presence of edema [change between baseline to 2 months]

      MRI image to verify the presence or absence of bone edema (dichotomous answer)

    4. presence of edema [change between baseline to 6 months]

      MRI image to verify the presence of absence or bone edema (dichotomous answer)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. history of heel pain for at least 3 months prior to enrollment,

    2. Pain on palpation of the medial calcaneal tubercle or proximal plantar fascia,

    3. plantar fascia thickness of 4.0 mm or greater.

    Exclusion Criteria:
    1. age below 18 years of age

    2. history of systemic disease

    3. pregnancy

    4. Previous surgery on the lower limbs

    5. diagnosis of fibromyalgia, neurological disease, Achilles tendinopathy, metatarsalgia, acute ankle sprain, tarsal tunnel syndrome, or heel joint syndrome

    6. body mass index (BMI) greater than 35 kg/m2

    7. wounds, infections in the treatment area

    8. altered sensation in the treatment area

    9. skin pigmentation alterations in the area to be treated (tattoo, dyschromia)

    10. metal implants in the treatment area

    11. History of oral or injected corticosteroid therapy within the past six weeks

    12. Diagnosis of neurological heel pain (radiculopathy)

    13. diagnosis of systemic inflammatory arthritis (rheumatoid arthritis, etc.)

    14. other acute pathologies (febrile fever, cold, etc.) requiring treatment

    15. other painful conditions requiring painkillers (toothache, back pain, etc.)

    16. neoplasms

    17. cardiac pacemaker or other device.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Angela Notarnicola Bari Italy 70124

    Sponsors and Collaborators

    • Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
    ClinicalTrials.gov Identifier:
    NCT05925777
    Other Study ID Numbers:
    • THEAL-fasc
    First Posted:
    Jun 29, 2023
    Last Update Posted:
    Jun 29, 2023
    Last Verified:
    Jun 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 29, 2023